Fluorescence nanozyme B-CDs@SiO

Li Wang, Lei Li, Wei Chen, Mingcui Zhang

Abstract read

In one paragraph

Article in Analytical and bioanalytical chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Li WangThe Key Laboratory of Functional Molecular Solids, Ministry of Education; Anhui Key Laboratory of Biomedical Materials and Chemical Measurement; College of Chemistry and Materials Science, Anhui Normal University, Wuhu, 241002, P.R. China.

Lei LiAnhui Province Key Laboratory of Non-Coding RNA Basic and Clinical Transformation; Central Laboratory, Yijishan Hospital, The First Affiliated Hospital of Wannan Medical College, Wuhu, 241001, P.R. China.

Wei ChenThe Key Laboratory of Functional Molecular Solids, Ministry of Education; Anhui Key Laboratory of Biomedical Materials and Chemical Measurement; College of Chemistry and Materials Science, Anhui Normal University, Wuhu, 241002, P.R. China.

Mingcui ZhangThe Key Laboratory of Functional Molecular Solids, Ministry of Education; Anhui Key Laboratory of Biomedical Materials and Chemical Measurement; College of Chemistry and Materials Science, Anhui Normal University, Wuhu, 241002, P.R. China. zhangmc@mail.ahnu.edu.cn.ORCID http://orcid.org/0000-0001-8087-766X

Funding

Health Research Program of Anhui AH WJ2022b046Key Projects of Natural Science Research of Universities in Anhui Province 2022AH051218National Natural Science Foundation of China 21175004Natural Science Foundation of Anhui Province 2108085MB68University Synergy Innovation Program of Anhui Province GXXT-2020-074

6 · The paper itself

Abstract

Acute myocardial infarction (AMI) poses a severe threat to human health, making its rapid and sensitive diagnosis crucial. Cardiac troponin I (cTnI) has been established as the gold standard biomarker for AMI diagnosis. Herein, a dual-mode immunosensor was constructed by integrating manganese dioxide (MnO

Indexed as

Cadmium CompoundsManganese CompoundsOxidesSilicon DioxideSulfidesTroponin IBiosensing TechniquesCarbonCarbon Quantum DotsColorimetryFluorescenceHumansImmunoassayLimit of DetectionMyocardial InfarctionSpectrometry, FluorescenceCadmium Compoundscadmium sulfideCarbonManganese Compoundsmanganese dioxideOxidesSilicon DioxideSulfidesTroponin ICarbon dotsCardiac troponin IDual-mode immunosensorMnO2SiO2

Identifiers

PMID41543532

DOI10.1016/j.microc.2025.115783

What OpenQuestion holds

Textmetadata

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.